Genes and Immunity: review time and acceptance speed

ISSN 1466-4879 · ISSN 1476-5470 · Springer Nature · Immunology and Microbiology

Half of the articles Genes and Immunity accepted in 2025 were accepted within 227 days of submission (n = 53); the middle half took 169–278 days.

Submission → acceptance (2025)
227 days median
middle half 169–278 · n = 53
Acceptance → online
15 days median
middle half 12–22 · n = 53
Open access · fees
Hybrid · ≈$3,190

Accepted articles only · dates deposited by the publisher in PubMed · data as of Sep 15, 2026

Plan submissions to a deadline — free

How long does Genes and Immunity take to accept a paper?

days0901802703602024: middle half 87–205 days1352024n=542025: middle half 169–278 days2272025n=53
Line = median; shaded box = middle half of articles (25th–75th percentile). Year of acceptance.
Days from submission to acceptance, by year of acceptance
YearArticles (n)25th pctMedian75th pct90th pctAccepted <14 daysHave a revised date
2025531692272780.0%100%
202454871352053.7%100%

Distribution in 2025

0–29 days: 0% (0 articles)030–59 days: 0% (0 articles)3060–89 days: 0% (0 articles)6090–119 days: 2% (1 articles)90120–149 days: 15% (8 articles)120150–179 days: 11% (6 articles)150180–209 days: 15% (8 articles)180210–239 days: 17% (9 articles)210240–269 days: 13% (7 articles)240270–299 days: 8% (4 articles)270300–329 days: 6% (3 articles)300330–359 days: 2% (1 articles)330360+ days: 11% (6 articles)360+days from submission to acceptance (30-day bins)
Show as a table
DaysArticlesShare
0–2900.0%
30–5900.0%
60–8900.0%
90–11911.9%
120–149815.1%
150–179611.3%
180–209815.1%
210–239917.0%
240–269713.2%
270–29947.5%
300–32935.7%
330–35911.9%
360+611.3%

From acceptance to online publication

After acceptance, half of the 2025 articles appeared online within 15 days (middle half 12–22 days, n = 53).

From submission to online publication, the median was 245 days (middle half 180–296 days, n = 53).

Read these numbers carefully

  • These times describe articles the journal accepted. Rejected manuscripts never appear in public data, so they cannot tell you how long a rejection takes.
  • Dates are the ones the publisher deposited with PubMed. Some publishers record the date a revised manuscript arrived as the submission date, which makes review look faster.
  • Invited articles and special issues can move faster than regular submissions.

Open access status and publishing fees

Hybrid (subscription journal with an open-access option). Listed APC: about $3,190 (as reported by OpenAlex).

OpenAPC has fewer than 5 reported payments for this journal in 2023–2025, so no typical amount is shown.

Many journals waive or reduce fees for authors from eligible countries or institutions with publishing agreements — check with the journal and your library.

Integrity and indexing signals

Facts from public records, shown without judgement. See the methodology for why each can be worth a closer look.

Listed in DOAJNo
Articles indexed for MEDLINE in 2025Yes
Retractions0 retracted articles among 219 added to PubMed in 2021–2025 (0.00 per 1,000), per the Retraction Watch Database.
Accepted within 14 days of submission0.0% of 2025 articles
Publication volume54 articles added to PubMed in 2025 (-4% vs 2024).

Topics and scope

Immunology and Microbiology journalsMedicine journalsImmunology journals

Similar journals — faster or cheaper, side by side

Journals publishing on the most similar topics (OpenAlex), ordered by similarity. Only 2025 figures are compared with the 2025 median of Genes and Immunity, 227 days.

Paid APC medianDOAJMEDLINE
Immunologic Research96 (2025, n = 142)≈$2,890NoYes
Clinical & Experimental Immunology160 (2025, n = 90)≈$3,816NoYes
Clinical Immunology80 (2025, n = 133)≈$4,400NoYes
Immunological Reviews33 (2025, n = 98)≈$5,000NoYes
ImmunoHorizons69 (2025, n = 84)$1,595YesYes
International Immunology93 (2025, n = 61)≈$3,530NoYes
Nature Immunology300 (2025, n = 167)≈$12,690$10,840 (10 payments)NoYes
Current Opinion in Immunology55 (2025, n = 147)≈$4,410NoYes
Immunity255 (2025, n = 216)≈$10,400$8,969 (9 payments)NoYes
European Journal of Immunology175 (2025, n = 215)≈$4,550NoYes

Frequently asked questions

How long does Genes and Immunity take to accept a paper?

Half of the articles Genes and Immunity accepted in 2025 were accepted within 227 days of submission (n = 53); the middle half took 169–278 days. Based on dates in PubMed for accepted articles only.

How long after acceptance are Genes and Immunity articles published online?

Half of the articles accepted in 2025 appeared online within 15 days of acceptance (n = 53).

Does Genes and Immunity charge an article processing charge (APC)?

Listed APC: about $3,190 (as reported by OpenAlex).

Sources and method

Journal identity: ISSN-L 1466-4879; NLM ID 100953417; OpenAlex record. Speed figures use 53 articles accepted in 2025 with valid dates; excluded records for that year: none.

Spotted a problem with this journal's data, or are you the publisher? Report a correction or email rafiq@gradsummit.com. Verified errors are corrected within five business days.

Get the free Journal Submission Go/No-Go Checklist

The pre-submission checks from Write and Publish a Scientific Paper: journal fit, formatting, cover letter and reviewer suggestions. We’ll email you the download link.

One email with your download, then occasional research tips. One-click unsubscribe, anytime. We never sell your data.

Get Write and Publish a Scientific Paper

Data sources. Submission, acceptance and publication dates: Courtesy of the U.S. National Library of Medicine (PubMed, entries through Sep 15, 2026). NLM does not endorse Journal Clock, and these figures may not reflect the most current PubMed data. Journal fees and open-access listing: DOAJ (CC0, retrieved Sep 16, 2026). Fees paid by institutions: OpenAPC (Open Database License, retrieved Sep 16, 2026). Retractions: Retraction Watch Database via Crossref (retrieved Sep 16, 2026). Journal identifiers and topics: OpenAlex (CC0). Currency conversion: ECB reference rates (Sep 15, 2026). How these numbers are calculated · For organisations.